{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T03:43:22Z","timestamp":1767930202507,"version":"3.49.0"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,1,19]]},"DOI":"10.7759\/cureus.52597","type":"journal-article","created":{"date-parts":[[2024,1,20]],"date-time":"2024-01-20T05:07:22Z","timestamp":1705727242000},"source":"Crossref","is-referenced-by-count":1,"title":["Comprehensive Management of Polycystic Ovarian Syndrome and Secondary Infertility: Optimizing Fertility Outcomes"],"prefix":"10.7759","author":[{"given":"Shivani","family":"Khemani","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akash","family":"More","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nancy","family":"Nair","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Namrata","family":"Choudhary","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jarul","family":"Shrivastava","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deepali","family":"Mamankar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2020.00287","article-title":"Cumulative live birth rates after the first art cycle using flexible GnRH antagonist protocol vs. standard long GnRH agonist protocol: a retrospective cohort study in women of different ages and various ovarian reserve","volume":"11","author":"Zhang W","year":"2020","unstructured":"Zhang W, Xie D, Zhang H, et al.. Cumulative live birth rates after the first art cycle using flexible GnRH antagonist protocol vs. standard long GnRH agonist protocol: a retrospective cohort study in women of different ages and various ovarian reserve. Front Endocrinol (Lausanne). 2020, 11:287. 10.3389\/fendo.2020.00287","journal-title":"Front Endocrinol (Lausanne)"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-08400-z","article-title":"Conventional GnRH antagonist protocols versus long GnRH agonist protocol in IVF\/ICSI cycles of polycystic ovary syndrome women\u00a0: a systematic review and meta-analysis","volume":"12","author":"Kadoura S","year":"2022","unstructured":"Kadoura S, Alhalabi M, Nattouf AH. Conventional GnRH antagonist protocols versus long GnRH agonist protocol in IVF\/ICSI cycles of polycystic ovary syndrome women\u00a0: a systematic review and meta-analysis. Sci Rep. 2022, 12:4456. 10.1038\/s41598-022-08400-z","journal-title":"Sci Rep"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1097\/j.pbj.0000000000000116","article-title":"Infertility management in women with polycystic ovary syndrome: a review","volume":"6","author":"Cunha A","year":"2021","unstructured":"Cunha A, P\u00f3voa AM. Infertility management in women with polycystic ovary syndrome: a review. Porto Biomed J. 2021, 6:116. 10.1097\/j.pbj.0000000000000116","journal-title":"Porto Biomed J"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1080\/09513590.2021.1958310","article-title":"Polycystic ovarian syndrome and infertility: overview and insights of the putative treatments","volume":"37","author":"Coll\u00e9e J","year":"2021","unstructured":"Coll\u00e9e J, Mawet M, Tebache L, Nisolle M, Brichant G. Polycystic ovarian syndrome and infertility: overview and insights of the putative treatments. Gynecol Endocrinol. 2021, 37:869-74. 10.1080\/09513590.2021.1958310","journal-title":"Gynecol Endocrinol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1186\/s43043-019-0002-1","article-title":"Comparative study between agonist and antagonist protocols in PCOS patients undergoing ICSI: a cross-sectional study","volume":"24","author":"Behery MA","year":"2019","unstructured":"Behery MA, Hasan EA, Ali EA, Eltabakh AA. Comparative study between agonist and antagonist protocols in PCOS patients undergoing ICSI: a cross-sectional study. Middle East Fertil Soc J. 2019, 24:10.1186\/s43043-019-0002-1","journal-title":"Middle East Fertil Soc J"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1002\/9781119622215.ch15","article-title":"The patient with polycystic ovaries","author":"Balen AH","year":"2021","unstructured":"Balen AH. The patient with polycystic ovaries. Assisted reproduction techniques: challenges and management options. Khaldoun S (ed): John Wiley & Sons Ltd., New Jersey, US; 2021. 1:96-102. 10.1002\/9781119622215.ch15"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.4103\/njcp.njcp_15_20","article-title":"Evaluation of sexual functions in infertile women with polycystic ovary syndrome","volume":"23","author":"Deniz A","year":"2020","unstructured":"Deniz A, Kehribar DY. Evaluation of sexual functions in infertile women with polycystic ovary syndrome. Niger J Clin Pract. 2020, 23:1548-54. 10.4103\/njcp.njcp_15_20","journal-title":"Niger J Clin Pract"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1186\/s13048-023-01171-9","article-title":"Depression, sexual function and sexual quality of life in women with polycystic ovary syndrome (PCOS) and healthy subjects","volume":"16","author":"Mojahed BS","year":"2023","unstructured":"Mojahed BS, Ghajarzadeh M, Khammar R, Shahraki Z. Depression, sexual function and sexual quality of life in women with polycystic ovary syndrome (PCOS) and healthy subjects. J Ovarian Res. 2023, 16:105. 10.1186\/s13048-023-01171-9","journal-title":"J Ovarian Res"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.4103\/2230-8210.107830","article-title":"Pregnancy in polycystic ovary syndrome","volume":"17","author":"Kamalanathan S","year":"2013","unstructured":"Kamalanathan S, Sahoo JP, Sathyapalan T. Pregnancy in polycystic ovary syndrome. Indian J Endocrinol Metab. 2013, 17:37-43. 10.4103\/2230-8210.107830","journal-title":"Indian J Endocrinol Metab"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2020.592495","article-title":"High BMI and insulin resistance are risk factors for spontaneous abortion in patients with polycystic ovary syndrome undergoing assisted reproductive treatment: a systematic review and meta-analysis","volume":"11","author":"Sun YF","year":"2020","unstructured":"Sun YF, Zhang J, Xu YM, Cao ZY, Wang YZ, Hao GM, Gao BL. High BMI and insulin resistance are risk factors for spontaneous abortion in patients with polycystic ovary syndrome undergoing assisted reproductive treatment: a systematic review and meta-analysis. Front Endocrinol (Lausanne). 2020, 11:592495. 10.3389\/fendo.2020.592495","journal-title":"Front Endocrinol (Lausanne)"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1093\/humupd\/dmx017","article-title":"GnRH antagonist versus long agonist protocols in IVF: a systematic review and meta-analysis accounting for patient type","volume":"23","author":"Lambalk CB","year":"2017","unstructured":"Lambalk CB, Banga FR, Huirne JA, et al.. GnRH antagonist versus long agonist protocols in IVF: a systematic review and meta-analysis accounting for patient type. Hum Reprod Update. 2017, 23:560-79. 10.1093\/humupd\/dmx017","journal-title":"Hum Reprod Update"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.3760\/cma.j.cn101441-20210112-00014","article-title":"Comparison of clinical outcome for long GnRH agonist protocol and flexible antagonist protocol in IVF\/ICSI for infertile patients with PCOS (Article in Chinese)","volume":"41","author":"Zhu Y","year":"2021","unstructured":"Zhu Y, Sun Y, Liu J, Mei J. Comparison of clinical outcome for long GnRH agonist protocol and flexible antagonist protocol in IVF\/ICSI for infertile patients with PCOS (Article in Chinese). Chin J Reprod Contracept. 2021, 41:776-82. 10.3760\/cma.j.cn101441-20210112-00014","journal-title":"Chin J Reprod Contracept"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1080\/01443615.2020.1870944","article-title":"Cabergoline versus calcium infusion in the prevention of ovarian hyperstimulation syndrome: a randomised controlled study","volume":"42","author":"Fouda UM","year":"2022","unstructured":"Fouda UM, Elshaer HS, Youssef GG, et al.. Cabergoline versus calcium infusion in the prevention of ovarian hyperstimulation syndrome: a randomised controlled study. J Obstet Gynaecol. 2022, 42:122-6. 10.1080\/01443615.2020.1870944","journal-title":"J Obstet Gynaecol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.808517","article-title":"Comparison of the effectiveness of various medicines in the prevention of ovarian hyperstimulation syndrome: a network meta-analysis of randomized controlled trials","volume":"13","author":"Wu D","year":"2022","unstructured":"Wu D, Shi H, Yu Y, Yu T, Zhai J. Comparison of the effectiveness of various medicines in the prevention of ovarian hyperstimulation syndrome: a network meta-analysis of randomized controlled trials. Front Endocrinol (Lausanne). 2022, 13:808517. 10.3389\/fendo.2022.808517","journal-title":"Front Endocrinol (Lausanne)"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.21608\/ebwhj.2018.7511","article-title":"Calcium infusion plus or minus cabergoline for prevention of ovarian hyperstimulation syndrome: randomized double-blind placebo-controlled trial","volume":"8","author":"Sharafeldeen A","year":"2018","unstructured":"Sharafeldeen A. Calcium infusion plus or minus cabergoline for prevention of ovarian hyperstimulation syndrome: randomized double-blind placebo-controlled trial. EBWHJ. 2018, 8:156-64. 10.21608\/ebwhj.2018.7511","journal-title":"EBWHJ"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.28804","article-title":"A case of severe ovarian hyperstimulation syndrome causing pleural effusion","volume":"14","author":"Khaja M","year":"2022","unstructured":"Khaja M, Powell S, Kandhi S, Stastka P, Yordanka DS, Ronderos DM. A case of severe ovarian hyperstimulation syndrome causing pleural effusion. Cureus. 2022, 14:28804. 10.7759\/cureus.28804","journal-title":"Cureus"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2011.04.094","article-title":"Intravenous calcium infusion as a novel preventive therapy of ovarian hyperstimulation syndrome for patients with polycystic ovarian syndrome","volume":"96","author":"Gurgan T","year":"2011","unstructured":"Gurgan T, Demirol A, Guven S, Benkhalifa M, Girgin B, Li TC. Intravenous calcium infusion as a novel preventive therapy of ovarian hyperstimulation syndrome for patients with polycystic ovarian syndrome. Fertil Steril. 2011, 96:53-7. 10.1016\/j.fertnstert.2011.04.094","journal-title":"Fertil Steril"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/217715-comprehensive-management-of-polycystic-ovarian-syndrome-and-secondary-infertility-optimizing-fertility-outcomes","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T20:12:47Z","timestamp":1707509567000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/217715-comprehensive-management-of-polycystic-ovarian-syndrome-and-secondary-infertility-optimizing-fertility-outcomes"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,19]]},"references-count":17,"URL":"https:\/\/doi.org\/10.7759\/cureus.52597","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1,19]]}}}